The Management of Infectious Diseases in Comorbidity with Tuberculosis
Author Contributions
Funding
Conflicts of Interest
References
- World Health Organization (WHO). Global Tuberculosis Report 2021; WHO: Geneva, Switzerland, 2021; Available online: https://www.who.int/publications/i/item/9789240037021 (accessed on 1 October 2022).
- Bates, M.; Marais, B.J.; Zumla, A. Tuberculosis Comorbidity with Communicable and Noncommunicable Diseases. Cold Spring Harb. Perspect. Med. 2015, 5, a017889. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bruchfeld, J.; Correia-Neves, M.; Kallenius, G. Tuberculosis and HIV Coinfection. Cold Spring Harb. Perspect. Med. 2015, 5, a017871. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization (WHO). Management of Tuberculosis and HIV Coinfection; WHO: Geneva, Switzerland, 2013; Available online: https://www.euro.who.int/__data/assets/pdf_file/0004/218515/Management-of-tuberculosis-and-HIV-coinfection-Eng.pdf (accessed on 1 October 2022).
- Manosuthi, W.; Wiboonchutikul, S.; Sungkanuparph, S. Integrated therapy for HIV and tuberculosis. AIDS Res. Ther. 2016, 13, 22. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pooranagangadevi, N.; Padmapriyadarsini, C. Treatment of Tuberculosis and the Drug Interactions Associated with HIV-TB Co-Infection Treatment. Front. Trop. Dis. 2022, 3, 834013. [Google Scholar] [CrossRef]
- Baluku, J.B.; Nassozi, S.; Gyagenda, B.; Namanda, M.; Andia-Biraro, I.; Worodria, W.; Byakika-Kibwika, P. Prevalence of Malaria and TB Coinfection at a National Tuberculosis Treatment Centre in Uganda. J. Trop. Med. 2019, 2019, 3741294. [Google Scholar] [CrossRef]
- Chen, L.; Bao, D.; Gu, L.; Gu, Y.; Zhou, L.; Gao, Z.; Huang, Y. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment. BMC Infect. Dis. 2018, 18, 295. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Khan, A.F.; Sajjad, A.; Mian, D.A.; Tariq, M.M.; Jadoon, U.; Abbas, M.; Shakeel, K.; Saeed, N.; Abbas, K. Co-infection With Hepatitis B in Tuberculosis Patients on Anti-tuberculosis Treatment and the Final Outcome. Cures 2021, 13, e14433. [Google Scholar] [CrossRef] [PubMed]
- Dubey, J.; Jones, J. Toxoplasma gondii infection in humans and animals in the United States. Int. J. Parasitol. 2008, 38, 1257–1278. [Google Scholar] [CrossRef] [PubMed]
- Mashaly, M.; Nabih, N.; Fawzy, I.; El Henawy, A. Tuberculosis/toxoplasmosis co-infection in Egyptian patients: A reciprocal impact. Asian Pac. J. Trop. Med. 2017, 10, 315–319. [Google Scholar] [CrossRef] [PubMed]
- Bhatia, R.S.; Uppal, R.; Malhi, R.; Behera, D.; Jindal, S.K. Drug interaction between rifampicin and cotrimoxazole in patients with tuberculosis. Hum. Exp. Toxicol. 1991, 10, 419–421. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Dzinamarira, T.; Imran, M.; Muvunyi, C.M. The Management of Infectious Diseases in Comorbidity with Tuberculosis. Medicina 2022, 58, 1406. https://doi.org/10.3390/medicina58101406
Dzinamarira T, Imran M, Muvunyi CM. The Management of Infectious Diseases in Comorbidity with Tuberculosis. Medicina. 2022; 58(10):1406. https://doi.org/10.3390/medicina58101406
Chicago/Turabian StyleDzinamarira, Tafadzwa, Mohd Imran, and Claude Mambo Muvunyi. 2022. "The Management of Infectious Diseases in Comorbidity with Tuberculosis" Medicina 58, no. 10: 1406. https://doi.org/10.3390/medicina58101406